Chemotherapy: Open Access
Open Access

International Conference on Antimicrobial Agents and Chemotherapy

August 04-06, 2015 Valencia, Spain

Scientific Tracks Abstracts

• Anti-VEGF alter cognitive functions and the CA1-CA3 hippocampal activity in mice: The first reported “Chemofog” with a targeted cancer therapy

  Helene Castel

  PDF HTML

• Evolution of cancer drug development and registration paradigms in light of the successes of immunotherapy

  Didier Coquoz

  PDF HTML

• Role of miR-29c in modulating the paracrine crosstalk between esophageal cancer cells and stromal fibroblasts in the tumor microenvironment

  Wen Wen Xu, Bin Li and Annie L M Cheung

  PDF HTML

• New synthetic anti-cancer compounds, LQB-118 and LQB-223, induce apoptosis by distinct mechanisms in glioblastoma cells

  Paula Sabbo Bernardo, Gustavo Henrique C Guimaraes, Fernanda Costas C de Faria and Raquel Ciuvalschi Maia

  PDF HTML

• Drug discovery beyond traditional medicines

  Isabel Portero Sanchez

  PDF HTML

• Is oncolytic virus a promising gene therapy for cancer?

  Dirk Buscher

  PDF HTML

• Production of advanced therapy products: Should it be scaled up to industry processes?

  Eva Martin Becerra

  PDF HTML

• Screening of novel antimalarial agents in RIKEN NPDepo

  Hiroyuki Osada, Hiroki Hayase, Yushi Futamura, Toshihiko Nogawa, Wierzba Konstanty and Nobumoto Watanabe

  PDF HTML

• Chemical genomics for target identification of antifungal theonellamides

  Minoru Yoshida

  PDF HTML

• Clindamycin & Primaquine for Pneumocystis jirovecii pneumonia; 27 years after

  Emil Toma and Maude Loignon

  PDF HTML

• Folk medicinal plant extracts as a source of biomolecules with antifungal properties against Candida species

  Natalia Martins, Isabel C F R Ferreira, Lillian Barros, Ana Maria Carvalho, Mariana Henriques and Sonia Silva

  PDF HTML

• The use of different phenolic compounds rich extracts obtained from cultivated thyme for antioxidant and antibacterial purposes

  Natalia Martins, Lillian Barros, Celestino Santos-Buelga, Sonia Silva, Mariana Henriques and Isabel C F R Ferreira

  PDF HTML

• Identification of miR-29c/FBXO31 as a key regulatory mechanism in esophageal cancer chemoresistance

  Bin Li, Wen Wen Xu, Jia Liu and Annie L M Cheung

  PDF HTML

• Some HIV protease inhibitors have also other beneficial, non-virological effects with potential therapeutic applications

  Maude Loignon and Emil Toma

  PDF HTML